Aureka Biotechnologies announced the completion of a US$100 million Series B financing round on August 10, 2026. Granite Asia provided the first tranche as the sole investor, while a leading …
The global pharmaceutical sector is entering a pivotal phase. Although the FDA Modernization Act 2.0 has opened the door for Non-Animal Models (NAMs), widespread adoption is still slowed by major …
